about
Management of differentiated thyroid cancer in the presence of resistance to thyroid hormone and TSH-secreting adenomas: a report of four cases and review of the literatureCerebellar mass as a primary presentation of papillary thyroid carcinoma: case report and literature reviewCurrent concepts and future directions in differentiated thyroid cancer.Identification of new biomarkers for human papillary thyroid carcinoma employing NanoString analysis.Explaining the increasing incidence of differentiated thyroid cancer.Surgical decision making in the management of well-differentiated thyroid cancer.Short-term Follow-up US Leads to Higher False-positive Results Without Detection of Structural Recurrences in PTMCMetabolic and cardiovascular risk in patients with a history of differentiated thyroid carcinoma: A case-controlled cohort study.Advances in cellular therapy for the treatment of thyroid cancer.Thyroid cancer in older men.American Thyroid Association statement on preoperative imaging for thyroid cancer surgery.Postoperative ultrasonography surveillance in patients with follicular thyroid carcinoma: a multicenter study.Histone deacetylase inhibitors upregulate Rap1GAP and inhibit Rap activity in thyroid tumor cells.Effects of recombinant human thyroid stimulating hormone on (131)I therapy for the treatment of differentiated thyroid cancer.Analysis of the prognostic significance of lymph node related characteristics in papillary thyroid carcinoma patients presenting with pre- or intra-operative evidence of cervical lymph node metastases.Thyroid hormone resistance in two patients with papillary thyroid microcarcinoma and their BRAFV600E mutation status.
P2860
Q26862777-920492A8-53F1-44A6-8F93-E721E520903AQ33475238-7AC212BF-0D4C-4013-B7DC-90A6E3D42E23Q33677589-6CF6C69B-A867-4846-B007-65C93D8F0680Q35793689-F0316E1F-81D8-41AA-AD5A-3EF6AAF6EAC6Q36131201-CE60A579-8E42-424E-9086-170448D0062BQ36240451-9E25FD96-8425-4A94-9824-A759B453D828Q36445070-99993946-23C0-4BE8-BEE7-B555C68A2381Q36958693-4CA39349-6CFE-4BC8-86DC-C8544FE71AB1Q37776660-1753A90C-6B47-467C-8162-29E1ABFF7C2CQ37810603-C0B87F9E-8F25-46A8-AF98-152E2DBBD181Q38246037-2C4F2AD2-DE6A-43F8-9192-F4899806F628Q39178789-F15994F3-1511-44AA-9E78-CEC70E5B290FQ39583011-37B2DD23-0BFC-4B67-A89F-AFCFB7B1DBCEQ41914116-C04F1C3A-B5DB-4D90-AD41-4FEFCB25E5B9Q51748004-C53C9256-DF65-4C0A-8F94-77539343618EQ53821838-BFEAE7AF-D2E5-4296-AD68-28840773A5DD
P2860
description
2007 nî lūn-bûn
@nan
2007 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Papillary thyroid cancer: monitoring and therapy
@ast
Papillary thyroid cancer: monitoring and therapy
@en
Papillary thyroid cancer: monitoring and therapy
@nl
type
label
Papillary thyroid cancer: monitoring and therapy
@ast
Papillary thyroid cancer: monitoring and therapy
@en
Papillary thyroid cancer: monitoring and therapy
@nl
prefLabel
Papillary thyroid cancer: monitoring and therapy
@ast
Papillary thyroid cancer: monitoring and therapy
@en
Papillary thyroid cancer: monitoring and therapy
@nl
P2093
P1476
Papillary thyroid cancer: monitoring and therapy
@en
P2093
Andrew J Martorella
R Michael Tuttle
Rébecca Leboeuf
P304
753-78, vii
P356
10.1016/J.ECL.2007.04.004
P407
P577
2007-09-01T00:00:00Z